Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study.
- DOI
- 10.1016/j.jcf.2021.10.013
- Published
- 2021-12-24
- Container
- J Cyst Fibros
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jcf.2021.10.013,
title = {Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study.},
author = {Meijer L and Hery-Arnaud G and Leven C and Nowak E and Hillion S and Renaudineau Y and Durieu I and Chiron R and Prevotat A and Fajac I and Hubert D and Murris-Espin M and Huge S and Danner-Boucher I and Ravoninjatovo B and Leroy S and Macey J and Urban T and Rault G and Mottier D and Berre RL.},
year = {2022},
journal = {J Cyst Fibros},
doi = {10.1016/j.jcf.2021.10.013},
url = {https://doi.org/10.1016/j.jcf.2021.10.013}
}RIS
TY - JOUR TI - Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study. AU - Meijer L AU - Hery-Arnaud G AU - Leven C AU - Nowak E AU - Hillion S AU - Renaudineau Y AU - Durieu I AU - Chiron R AU - Prevotat A AU - Fajac I AU - Hubert D AU - Murris-Espin M AU - Huge S AU - Danner-Boucher I AU - Ravoninjatovo B AU - Leroy S AU - Macey J AU - Urban T AU - Rault G AU - Mottier D AU - Berre RL. PY - 2022 JO - J Cyst Fibros DO - 10.1016/j.jcf.2021.10.013 UR - https://doi.org/10.1016/j.jcf.2021.10.013 ER -
APA
L, M., G, H., C, L., E, N., S, H., Y, R., I, D., R, C., A, P., I, F., D, H., M, M., S, H., I, D., B, R., S, L., J, M., T, U., G, R., D, M., & RL., B. (2022). Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study.. J Cyst Fibros. https://doi.org/10.1016/j.jcf.2021.10.013
Source records
- europe-pmc · retrieved 2026-09-27T03:09:54.725Z
- hal · retrieved 2026-09-27T03:09:54.762Z